These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26502132)

  • 21. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 22. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Vickers A
    Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.
    Hutchinson R; Akhtar A; Haridas J; Bhat D; Roehrborn C; Lotan Y
    Cancer; 2016 Dec; 122(24):3785-3793. PubMed ID: 27658175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer screening.
    Eastham J
    Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
    Subramanian V; Kattan MW
    Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
    [No Abstract]   [Full Text] [Related]  

  • 27. PSA screening: the USPSTF got it right.
    Lefevre M
    J Fam Pract; 2013 Nov; 62(11):617, 619. PubMed ID: 24288702
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigation momentum: the relentless pursuit to resolve uncertainty.
    Sah S; Elias P; Ariely D
    JAMA Intern Med; 2013 May; 173(10):932-3. PubMed ID: 23588200
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current aspects of prostate cancer screening].
    Jalón Monzón A; Escaf Barmadah S; Viña Alonso LM; Jalón Monzón M
    Semergen; 2017; 43(5):387-393. PubMed ID: 27562331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspective on Prostate Cancer Screening.
    Carlsson SV; Lilja H
    Clin Chem; 2019 Jan; 65(1):24-27. PubMed ID: 30459166
    [No Abstract]   [Full Text] [Related]  

  • 32. Missing the mark on prostate-specific antigen screening.
    Miller DC; Hollenbeck BK
    JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
    Andriole GL; Kibel AS
    Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer screening: the need for problem-solving that puts men's interests first.
    Holmberg L
    Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
    [No Abstract]   [Full Text] [Related]  

  • 35. [Not Available].
    Larsson LT; Kain J; Bratt O
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29437198
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathology consultation on prostate-specific antigen testing.
    Noguez JH; Fantz CR
    Am J Clin Pathol; 2014 Jul; 142(1):7-15. PubMed ID: 24926079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Prostate-specific antigen-based prostate cancer screening: Past and future.
    Birkeland S
    Int J Urol; 2016 Apr; 23(4):348. PubMed ID: 26839978
    [No Abstract]   [Full Text] [Related]  

  • 38. The science and art of prostate cancer screening.
    Yao SL; Lu-Yao GL
    J Natl Cancer Inst; 2011 Mar; 103(6):450-1. PubMed ID: 21350220
    [No Abstract]   [Full Text] [Related]  

  • 39. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial Comment to Prostate-specific antigen-based prostate cancer screening: Past and future.
    Sakamoto S
    Int J Urol; 2015 Jun; 22(6):532-3. PubMed ID: 25854711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.